Endorotor
Payments companies reported to CMS as associated with Endorotor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endorotor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endorotor
These are the largest totals companies reported as associated with Endorotor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rushikesh Shah | Dallas, TX | Gastroenterology (Internal Medicine) | $67.29 |
| Sarah Loudermilk | Greenville, SC | Family | $67.29 |
| Jeremy Polman | New York, NY | Gastroenterology (Internal Medicine) | $62.81 |
| David Robbins | New York, NY | Gastroenterology (Internal Medicine) | $62.81 |
| Evin Mccabe | New York, NY | Internal Medicine | $62.81 |
| Arvind Trindade | New Brunswick, NJ | Gastroenterology (Internal Medicine) | $62.81 |
| Nichol Martinez | Philadelphia, PA | Gastroenterology (Internal Medicine) | $62.81 |
| Michael Ma | New York, NY | Gastroenterology (Internal Medicine) | $62.81 |
| Victoria Garland | New York, NY | Gastroenterology (Internal Medicine) | $62.81 |
| Isabella Bergagnini | New York, NY | Internal Medicine | $62.81 |
Prescribed Endorotor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.